$VICR

VINCIARELLI PATRIZIO sold $6.6M of VICR

VINCIARELLI PATRIZIO (Chairman & CEO) sold 20,000 shares of VICOR CORP (VICR) at an average of $330.74 ($324.54–$340.08, $6.61M total) across 13 trades on 2026-06-18 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · VINCIARELLI PATRIZIO
Published Jun 22, 2026, 3:08 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 22, 2026, 3:12 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$VICR
Neutral
medium confidence
Mentioned
$VICR
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VICRNeutralLow
01

Why it matters

The disclosure can influence short-term sentiment, but without accompanying guidance, earnings, or operational changes, it is unlikely to drive a durable repricing.

02

Market read

A routine 10b5-1 insider sale is newly disclosed with transaction-level detail, offering limited incremental trading edge absent other catalysts.

03

What to watch

Traders may overreact to insider sales; the key incremental data here is the disclosed price range and remaining holdings, not a new business catalyst.

Relevance 5/10Novelty 5/10Timing: after-hours/filing update (Form 4 filed 2026-06-22) following 2026-06-18 sales

Background

The article is an SEC Form 4 insider transaction: VICR’s Chairman & CEO (Vinciareli Patrizio) sold shares in an open-market sale under a 10b5-1 plan.

Company-level read

Ticker impact

$VICRNeutralMedium confidence
Context

VICR CEO/Chairman sold about $6.6M of VICR shares via an open-market sale under a pre-arranged 10b5-1 plan on 2026-06-18.

Expected impact

Likely limited immediate price impact; any reaction may be short-lived unless accompanied by other new fundamentals.

Evidence & confidence

The filing provides transaction details (shares, price range, total value) but does not include new operating/financial information; 10b5-1 generally reduces interpretive weight of the sale.

Market effects

No sector-wide implications; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect routine liquidity rather than bearish expectations.

Key entities

  • VICOR CORP

    Subject of the Form 4 insider sale; shares sold total ~$6.6M across 13 trades.

  • VINCIARELLI PATRIZIO

    Chairman & CEO and 10% owner who executed the sale under a pre-arranged 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$MXLHighAI 8/10

MXL vs. VICR: Which Has the Better AI Infrastructure Opportunity?

MaxLinear (MXL) and Vicor (VICR) are positioned to benefit from AI infrastructure growth. MXL reported 55% revenue growth in Q2 2026, driven by optical and electrical interconnects. Vicor focuses on power delivery for AI processors. MXL's AI products, like Keystone and Rushmore, are in high demand, with new products expected to launch in 2027 and 2028.

$VICRMedAI 8/10

Vicor (VICR) Q2 2026 Earnings Call Transcript

Vicor’s Q2 2026 earnings call reported product and royalty revenue of $143.4M, up 26.9% sequentially and 1.6% year over year. Advanced products revenue rose to $94.2M. Net income was $49.8M, GAAP diluted EPS $1.40, and cash was $453.6M. The company guided for nearly 10% Q3 revenue growth and over $600M 2026 revenue, citing capacity increases and licensing assumptions.

$VICRMed

Vicor Corp (VICR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth

Vicor Corp said a new license agreement will bring $5 million quarterly payments in year one and $10 million in year two, with $15 million contributing to Q2 revenue and additional revenue recognition expected in Q3 and subsequent quarters. Management also discussed fab capacity expansion to support a $2.5 billion revenue goal and said backlog growth stems mainly from existing customer demand.

$VICRMed

VICOR CORP (VICR): Results of Operations and Financial Condition

VICOR CORP (VICR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d115827dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 NEWS RELEASE FINANCIAL NEWS BRIEF July 21, 2026 For Immediate Release Vicor Corporation Reports Results for the Second Quarter Ended June 30, 2026 Andover, Mass., July 21, 2026 (GLOBE NEWSWIRE) — Vicor Corporation (NASDAQ: